Peer-influenced content. Sources you trust. No registration required. This is HCN.
Hematology Advisor
A rare case of anti-ER5-mediated hemolytic disease of the fetus and newborn required international sourcing of ultrarare blood products and multiple intrauterine transfusions, highlighting the complexity of managing alloimmunization involving newly recognized high-incidence red blood cell antigens.
Hematology October 21st 2026
MDLinx
A report examining allegations against a Montana oncologist highlights the challenges of investigating physician misconduct, balancing due process with patient safety, and addressing barriers that may discourage healthcare professionals from reporting concerns.
All Specialties October 21st 2026
A young child with an inherited tumor-predisposition syndrome develops recurrent bilateral visual decline after completing first-line chemotherapy for a radiographically diagnosed optic pathway tumor, requiring reassessment of treatment urgency, systemic options, and surveillance.
Medical Genetics October 19th 2026
MD Newsline
A patient with advanced follicular lymphoma described a prolonged diagnostic journey marked by evolving symptoms, initial alternative diagnoses, urgent treatment initiation, and the psychological challenges that continued long after active therapy began.
Hematology October 12th 2026
Cureus
A case report describes duodenal ulcer perforation in a woman receiving tirzepatide for weight loss, occurring shortly after dose escalation, though important confounders prevent conclusions about a causal drug relationship.
Emergency Medicine October 1st 2026
SAGE Open Medical Case Reports (SCO)
Three adults receiving semaglutide or tirzepatide preserved or increased lean soft tissue while losing weight alongside resistance training and protein-focused diets, although the uncontrolled case series cannot determine which strategies produced these outcomes.
Endocrinology, Diabetes, Metabolism October 1st 2026